Net income
−$31.6M
−66.2% vs same quarter last year
EPS, diluted
−$0.15
+28.6% vs same quarter last year
Operating cash flow
−$37.7M
−217.3% vs same quarter last year
Operating income
−$35.7M
−71.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $41K | −$88.1M |
| FY24 | $20K | −$95.1M |
| FY23 | $426K | −$88.4M |
| FY22 | - | −$84.7M |
| FY21 | $4.4M | −$97.1M |
| FY20 | $8.2M | −$49M |
| FY19 | $5.8M | −$20.5M |
| FY18 | $10.3M | −$39.2M |
| FY17 | $10.7M | −$46.4M |
| FY16 | $3.2M | - |
| FY15 | - | −$3.4M |
| FY14 | - | −$10M |
| FY13 | - | −$11.7M |
| FY12 | - | −$4.9M |
| FY11 | $24.3M | −$3.8M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −230461% | −214861% |
| FY24 | −515860% | −475295% |
| FY23 | −22518.5% | −20762.2% |
| FY22 | - | - |
| FY21 | −2197.4% | −2201.4% |
| FY20 | −669.5% | −599.2% |
| FY19 | −370% | −353.7% |
| FY18 | −414.6% | −379.2% |
| FY17 | −484.7% | −432.3% |
| FY16 | −342.7% | - |
| FY15 | - | - |
| FY14 | - | - |
| FY13 | - | - |
| FY12 | - | - |
| FY11 | −48.3% | −15.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$67.5M |
| FY24 | - |
| FY23 | −$75.9M |
| FY22 | −$62.7M |
| FY21 | −$90.4M |
| FY20 | −$34.5M |
| FY19 | −$9.6M |
| FY18 | −$10.4M |
| FY17 | −$20.3M |
| FY16 | −$6.5M |
| FY15 | −$3.3M |
| FY14 | −$8.6M |
| FY13 | −$7.3M |
| FY12 | - |
| FY11 | −$7.9M |
- Altimmune
- Healthcare median
Show the numbers
| Year | Altimmune | Healthcare median |
|---|---|---|
| FY25 | −214861% | −30.6% |
| FY24 | −475295% | −47% |
| FY23 | −20762.2% | −58% |
| FY22 | - | −80.4% |
| FY21 | −2201.4% | −71.9% |
| FY20 | −599.2% | −62.2% |
| FY19 | −353.7% | −46.3% |
| FY18 | −379.2% | −49.6% |
| FY17 | −432.3% | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −38.4% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |
| FY11 | −15.6% | −27.9% |